ATE426665T1 - Gene des 20q13 amplikons und deren verwendungen - Google Patents

Gene des 20q13 amplikons und deren verwendungen

Info

Publication number
ATE426665T1
ATE426665T1 AT97932612T AT97932612T ATE426665T1 AT E426665 T1 ATE426665 T1 AT E426665T1 AT 97932612 T AT97932612 T AT 97932612T AT 97932612 T AT97932612 T AT 97932612T AT E426665 T1 ATE426665 T1 AT E426665T1
Authority
AT
Austria
Prior art keywords
sequences
amplicon
genes
diseases
chromosome
Prior art date
Application number
AT97932612T
Other languages
English (en)
Inventor
Joe Gray
Colin Collins
Soo-In Hwang
Tony Godfrey
David Kowbel
Johanna Rommens
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/680,395 external-priority patent/US5892010A/en
Priority claimed from US08/731,499 external-priority patent/US7049424B2/en
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE426665T1 publication Critical patent/ATE426665T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97932612T 1996-07-15 1997-07-15 Gene des 20q13 amplikons und deren verwendungen ATE426665T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/680,395 US5892010A (en) 1996-07-15 1996-07-15 Genes from the 20Q13 amplicon and their uses
US08/731,499 US7049424B2 (en) 1996-07-15 1996-10-16 Genes from the 20Q13 amplicon and their uses
US08/785,532 US7455964B1 (en) 1996-07-15 1997-01-17 Genes from the 20q13 amplicon and their uses

Publications (1)

Publication Number Publication Date
ATE426665T1 true ATE426665T1 (de) 2009-04-15

Family

ID=40029449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932612T ATE426665T1 (de) 1996-07-15 1997-07-15 Gene des 20q13 amplikons und deren verwendungen

Country Status (4)

Country Link
US (3) US7455964B1 (de)
EP (1) EP2113566B1 (de)
AT (1) ATE426665T1 (de)
DE (1) DE69739328D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976790A (en) * 1992-03-04 1999-11-02 The Regents Of The University Of California Comparative Genomic Hybridization (CGH)
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US20110013479A1 (en) * 2009-07-15 2011-01-20 Bodhisattwa Chaudhuri Multi-Dimensional Rotary Mixer
EP2275569A1 (de) 2009-07-17 2011-01-19 Centre Leon Berard ZNF217 Ein neuer prognostischer und prädiktiver Biomarker rekurrenter, invasiver oder metastatischer Phänotypen bei Krebs
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009A (en) * 1841-03-18 Improvement in machines for boring war-rockets
US2006A (en) * 1841-03-16 Clamp for crimping leather
US4254082A (en) 1978-06-12 1981-03-03 Miles Laboratories, Inc. Specific binding-adsorbent assay test means
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
JPS58215453A (ja) 1982-06-09 1983-12-14 Toray Silicone Co Ltd 室温硬化後塗装可能なオルガノポリシロキサン組成物
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
ES2018959A6 (es) 1988-11-15 1991-05-16 Univ Yale Metodo de delineacion de cromosomas humanos individuales en celulas metafasicas e interfasicas mediante hibridacion de suspension in situ.
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
AU647741B2 (en) 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
ZA915422B (en) 1990-07-11 1993-04-13 Genetype Ag Genomic mapping method by direct haplotyping using intron sequence analysis variations.
TW280833B (de) 1990-12-27 1996-07-11 Hoffmann La Roche
EP0533006A1 (de) 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimäre Interleukin 5-Rezeptor/Immunoglobulin-Polypeptide
US5976790A (en) 1992-03-04 1999-11-02 The Regents Of The University Of California Comparative Genomic Hybridization (CGH)
EP1134293A3 (de) 1992-03-04 2004-01-07 The Regents of The University of California Vergleichende Genomhybridisierung
WO1993024514A1 (en) 1992-05-26 1993-12-09 Mitotix D-type cyclin and uses related thereto
CA2096497A1 (en) 1992-05-26 1993-11-27 Patricia Anne Spears Mycobacteria probes
US6319687B1 (en) * 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
BR9306576A (pt) 1992-06-17 1999-01-12 Commw Scient Ind Res Org Xilanase recombinante
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5426039A (en) 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
EP0679716A4 (de) * 1993-11-12 1999-06-09 Kenichi Matsubara Genetische Signaturen.
US5573935A (en) 1994-01-18 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Protein tyrosine kinase A6
JPH07289297A (ja) 1994-02-10 1995-11-07 Eisai Co Ltd 癌抑制遺伝子
JPH0892285A (ja) 1994-09-21 1996-04-09 Japan Found Cancer Res ヒトｃｌａｐ蛋白質およびそれをコードするｄｎａ
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
SE510359C3 (sv) 1995-09-28 1999-06-21 Modul System Sweden Ab Foerfarande foer debitering medelst parkeringsautomater vid parkering
US7455964B1 (en) * 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US5801021A (en) * 1995-10-20 1998-09-01 The Regents Of The University Of California Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer
US5892010A (en) 1996-07-15 1999-04-06 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US7049424B2 (en) * 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
EP0960197B1 (de) 1996-07-15 2009-03-25 The Regents Of The University Of California GENE DES 20q13 AMPLIKONS UND DEREN VERWENDUNGEN
AU774736B2 (en) 1996-07-15 2004-07-08 Hospital For Sick Children, The Genes from 20q13 Amplicon and their uses
JP2005521382A (ja) 2001-09-28 2005-07-21 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質

Also Published As

Publication number Publication date
JP2008283970A (ja) 2008-11-27
US8993251B2 (en) 2015-03-31
US8101370B2 (en) 2012-01-24
US20090155789A1 (en) 2009-06-18
DE69739328D1 (de) 2009-05-07
US7455964B1 (en) 2008-11-25
EP2113566A1 (de) 2009-11-04
EP2113566B1 (de) 2012-08-22
JP4437179B2 (ja) 2010-03-24
US20130095475A1 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
CA2171110A1 (en) Detection of amplified or deleted chromosomal regions
CA2300355A1 (en) Detection of genetic alterations of chromosome 20q that are associated with breast cancer
DE69842099D1 (de) 5' ESTs für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
PT1292294E (pt) Utilização de triglicéridos de cadeia média para tratamento e prevenção da doença de alzheimer
Bellivier et al. Serotonin transporter gene and manic depressive illness: an association study.
AU8132194A (en) Single nucleotide polymorphisms and their use in genetic analysis
NZ284412A (en) Apolipoprotein E polymorphism and treatment of Alzheimer's Disease
ATE318934T1 (de) Verfahren zum nachweis von ki-ras mutationen
WO1999057322A3 (en) Genotyping the human udp-glucuronosyltransferase 1 (ugt1) gene
SI1458888T1 (sl) Metode zdravljenja psihoze in shizofrenije na osnovi polimorfizmov gena cntf
EP1063294A4 (de) Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
Gurish et al. A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14
ATE328078T1 (de) 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
ATE426665T1 (de) Gene des 20q13 amplikons und deren verwendungen
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
WO2000063441A3 (en) Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
EP0660844A4 (de) Isolierte nukleotid-sequenzen zum nachweis von neisseria gonorrhoeae.
ATE519859T1 (de) Verfahren zur herstellung von ausgewählten intermolekularen quervernetzungen in nukleinsäuren und ihre verwendungen
WO2004040016A3 (en) Genetic markers on chromosome 12 associated to bipolar or unipolar disorders
ATE348158T1 (de) Neuartiges collectin
GB9301453D0 (en) Nucleotide proves
DK1018559T3 (da) Phosphodiesteraser
EP1472375A4 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
WO2001023410A3 (en) Drug target isogenes: polymorphisms in the interleukin 13 gene
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties